logo-loader
WeedMD Inc.

WeedMD gets coveted outdoor pot cultivation licence from Health Canada

The company will commence planting more than 20,000 clones in early June with plans to harvest in fall 2019, increasing potential production output by an additional 27,000 kilograms

Cannabis outdoors
WeedMD now has a combined indoor and outdoor production footprint of over 5.2 million square feet

WeedMD Inc (CVE:WMD) (OTCMKTS:WDDMF) unveiled news Friday that it has received an outdoor pot cultivation licence from Health Canada, marking a promising start to the summer. 

Shares responded, up 2.2% at C$1.88 in Toronto, up 1.4% at US$1.39 in New York. 

The firm said it has secured Health Canada approval for 27 acres of low-cost, outdoor cultivation at its Strathroy, Ontario property.

It will start planting more than 20,000 clones in early June with plans to harvest in fall 2019, increasing potential production output by an additional 27,000 kgs.

READ: WeedMD posts 23% jump in first-quarter revenue to C$3.3 million

"Our ability to scale, coupled with our team's proven experience in growing our proprietary genetics outdoors, positions us as a first-mover in the industry," said CEO Keith Merker in a statement. "We have put together the most compelling outdoor cultivation plan in the industry and this licence is the final piece of that plan to fall into place."

The company now has a combined indoor and outdoor production footprint of over 5.2 million sqquare feet, with a projected annual output of 150,000 kilograms of cannabis by 2020, 

"WeedMD is leading the way by bringing its unique outdoor cultivation plan online in record time," said Derek Pedro, chief cannabis officer of WeedMD. "With construction, irrigation and security complete and more than 20,000 live plants propagated, prepped and ready to be planted, we are on track for a successful harvest this fall."

Outdoor cultivation and production strategy

The firm said that with its Health Canada licence amendment secured, it will have 27 acres of organically-certified soil for its newly-licensed Phase 1 grow.

In Phase 2, 100 acres of production is planned in 2020 on the existing property. The outdoor cultivation area is directly adjacent to WeedMD's existing licensed greenhouse facility, with infrastructure and human resources onsite, as well as municipal approval secured. 

WeedMD's cultivation team has experience growing outside, and has selected strains that have proved to excel outdoors in southwestern Ontario.

The firm announced that more than 20,000 clones are already rooted in organic material and are ready to be planted.

--updated share price--

Contact Katie Lewis at [email protected]

Quick facts: WeedMD Inc.

Price: $1.51

Market: TSX-V
Market Cap: $171.79 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of WeedMD Inc. named herein, including the promotion by the Company of WeedMD Inc. in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

There's a new cannabis ETF in town: Innovation Shares launches new,...

Innovation Shares LLC Managing Director Matt Markiewicz tells Proactive Investors the exchange-traded fund company has recently launched The Cannabis ETF (NYSE:THCX). Markiewicz says the passively managed ETF will focus on 35 companies in the legal marijuana space, including Radient...

on 07/12/2019

2 min read